ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,304.72
0.70%
US Tech 100
18,318.00
0.95%
다우존스 지수
39,069.59
0.01%
Bitcoin
69,441.06
1.36%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 영국
  5. LSE
  6. Bivictrix Therapeutics Plc (BVX)

  7. Bivictrix Therapeutics Plc (BVX) 뉴스

BVX

Bivictrix Therapeutics (BVX)

Bivictrix Therapeutics Plc
일자:
정렬 기준:
 검색 관련기사 보기:LSE:BVX
일자시간출처헤드라인심볼기업
2024/04/1722:23Alliance NewsAlliance NewsBivictrix granted FDA orphan drug status for rare cancer treatmentLSE:BVXBivictrix Therapeutics Plc
2024/04/1715:00RNS Regulatory NewsBiVictriX Therapeutics PLC Orphan Drug Designation & FDA INTERACT MeetingLSE:BVXBivictrix Therapeutics Plc
2024/03/2816:00RNS Regulatory NewsBiVictriX Therapeutics PLC Grant of Options – PDMR/Director DealingsLSE:BVXBivictrix Therapeutics Plc
2024/01/0421:30UK RegulatoryBiVictriX Therapeutics PLC Holding(s) in CompanyLSE:BVXBivictrix Therapeutics Plc
2024/01/0421:30UK RegulatoryBiVictriX Therapeutics PLC Holding(s) in CompanyLSE:BVXBivictrix Therapeutics Plc
2024/01/0416:00UK RegulatoryBiVictriX Therapeutics PLC BiVictriX Hosts Inaugural Roundtable DiscussionLSE:BVXBivictrix Therapeutics Plc
2023/12/0520:08UK RegulatoryBiVictriX Therapeutics PLC Board ChangeLSE:BVXBivictrix Therapeutics Plc
2023/11/3021:08Alliance NewsAlliance NewsIN BRIEF: Bivictrix selects final sequences for lead tumour programmeLSE:BVXBivictrix Therapeutics Plc
2023/11/3016:00UK RegulatoryBiVictriX Therapeutics PLC Pipeline update on BVX002LSE:BVXBivictrix Therapeutics Plc
2023/11/2302:14UK RegulatoryBiVictriX Therapeutics PLC Holding(s) in CompanyLSE:BVXBivictrix Therapeutics Plc
2023/11/1522:05Alliance NewsAlliance NewsTRADING UPDATES: BiVictriX patent boost; 4Global deal extendedLSE:BVXBivictrix Therapeutics Plc
2023/11/1516:00UK RegulatoryBiVictriX Therapeutics PLC Patent Granted in JapanLSE:BVXBivictrix Therapeutics Plc
2023/10/1220:04Alliance NewsAlliance NewsBivictrix says BVX001 increases survival rates by more than doubleLSE:BVXBivictrix Therapeutics Plc
2023/10/1215:00UK RegulatoryBiVictriX Therapeutics PLC Extended Survival Rates Reported with BVX001LSE:BVXBivictrix Therapeutics Plc
2023/10/0320:06Alliance NewsAlliance NewsBivictrix hires new CFO as Alex Hughes steps down after seven monthsLSE:BVXBivictrix Therapeutics Plc
2023/10/0315:00UK RegulatoryBiVictriX Therapeutics PLC Appointment of Adrian Howd as CFO and CBOLSE:BVXBivictrix Therapeutics Plc
2023/09/2001:30Alliance NewsAlliance NewsTRADING UPDATES: AEW UK REIT appoints new chair; Oberon raises moneyLSE:BVXBivictrix Therapeutics Plc
2023/09/1915:00UK RegulatoryBiVictriX Therapeutics PLC Interim ResultsLSE:BVXBivictrix Therapeutics Plc
2023/08/3115:00UK RegulatoryBiVictriX Therapeutics PLC Total Voting RightsLSE:BVXBivictrix Therapeutics Plc
2023/08/2317:30Alliance NewsAlliance NewsBivictrix Therapeutics granted US patent for cancer drug BVX001LSE:BVXBivictrix Therapeutics Plc
2023/08/2315:00UK RegulatoryBiVictriX Therapeutics PLC US Patent GrantedLSE:BVXBivictrix Therapeutics Plc
2023/08/1715:00UK RegulatoryBiVictriX Therapeutics PLC Holding(s) in CompanyLSE:BVXBivictrix Therapeutics Plc
2023/08/1702:00UK RegulatoryBiVictriX Therapeutics PLC Holding(s) in CompanyLSE:BVXBivictrix Therapeutics Plc
2023/08/1200:17UK RegulatoryBiVictriX Therapeutics PLC Holding(s) in CompanyLSE:BVXBivictrix Therapeutics Plc
2023/08/0901:18UK RegulatoryBiVictriX Therapeutics PLC Result of General MeetingLSE:BVXBivictrix Therapeutics Plc
2023/07/2003:30Alliance NewsAlliance NewsUPDATE: Bivictrix Therapeutics raises GBP2.1 million through fundraiseLSE:BVXBivictrix Therapeutics Plc
2023/07/2002:16UK RegulatoryBiVictriX Therapeutics PLC Result of Conditional FundraiseLSE:BVXBivictrix Therapeutics Plc
2023/07/1922:12Alliance NewsAlliance NewsIN BRIEF: Bivictrix to raise more than GBP2 million via placingLSE:BVXBivictrix Therapeutics Plc
2023/07/1920:31UK RegulatoryBiVictriX Therapeutics PLC Proposed Fundraise in excess of GBP2 millionLSE:BVXBivictrix Therapeutics Plc
2023/07/1721:57Alliance NewsAlliance NewsBivictrix Therapeutics hails positive data in final leukaemia studyLSE:BVXBivictrix Therapeutics Plc
 검색 관련기사 보기:LSE:BVX

최근 히스토리

NYSE
BCSF.RT
Bain Capital Specialty F...
NASDAQ
TXMXX
Cash Account Trust Tax-Exempt Ca
BIT
1KHC
Kraft Heinz
LSE
KLMG
Am Green Gbph
BIT
F17004
Vontobel Financial Produ...
BOV
NVIF11
Nova I Fundo Investiment...
USOTC
HLLGY
Hella Gmbh and Company K... (PK)
ASX
SPFKOB
GATE
SPELLFIREUSDT
SPELLFIRE Token
HUOB
DIEUSDT
Die Protocol
TSX
LUG
Lundin Gold
EU
S968S
S968S
NYSE
PANA.WS
Panacea Acquisition
SUSHI
HOGEETH
hoge.finance
BIBX
4NEOUSDT
NEO
NASDAQ
CLOE
Clover Leaf Capital
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유